Cargando…
Comparative efficacy of experimental inactivated and live-attenuated chimeric porcine circovirus (PCV) 1-2b vaccines derived from PCV1 and PCV2b isolates originated in China
BACKGROUND: Porcine circovirus type-2b (PCV2b) is recognized as the etiological agent of the various clinical manifestations of porcine circovirus-associated disease (PCVAD). Previous studies have demonstrated effectiveness of chimeric PCV1-2 vaccines against PCV2b challenge. In this study, the effi...
Autores principales: | Li, Jizong, Yu, Tianqi, Wang, Xiaobo, Zhou, Jinzhu, Gao, Ruxia, Zhang, Feipeng, Gao, Xing, Gao, Song, Liu, Xiufan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518523/ https://www.ncbi.nlm.nih.gov/pubmed/26220290 http://dx.doi.org/10.1186/s12985-015-0338-9 |
Ejemplares similares
-
Evaluation of the Efficacy and Cross-Protective Immunity of Live-Attenuated Chimeric PCV1-2b Vaccine Against PCV2b and PCV2d Subtype Challenge in Pigs
por: Huan, Changchao, et al.
Publicado: (2018) -
Genotype Shift of Malaysian Porcine Circovirus 2 (PCV2) from PCV2b to PCV2d within a Decade
por: Tan, Chew Yee, et al.
Publicado: (2022) -
Comparative Efficacy of Chimeric Porcine Circovirus (PCV) Vaccines against Experimental Heterologous PCV2d Challenges
por: Wongchanapai, Pichanun, et al.
Publicado: (2023) -
Reduction of porcine circovirus type 2 (PCV2) viremia by a reformulated inactivated chimeric PCV1-2 vaccine-induced humoral and cellular immunity after experimental PCV2 challenge
por: Seo, Hwi Won, et al.
Publicado: (2012) -
Evidence of Porcine Circovirus Type 2 (PCV2) Genetic Shift from PCV2b to PCV2d Genotype in Sardinia, Italy
por: Dei Giudici, Silvia, et al.
Publicado: (2023)